Cohen E B, Gang D L, Zeldis J B
Charles A. Dana Research Institute, Boston, Massachusetts.
Dig Dis Sci. 1987 Dec;32(12):1428-30. doi: 10.1007/BF01296671.
An association between non-A, non-B hepatitis and hepatocellular carcinoma has been made on the basis of negative serological markers for hepatitis B virus (HBV); however, hepatocellular carcinomas have been found to contain hepatitis B virus deoxyribonucleic acid (HBV DNA) in individuals who lack serological markers of HBV infection. Therefore, reports which ascribed a hepatocellular carcinoma to non-A, non-B hepatitis but did not examine the tumor for HBV DNA are open to question. We describe a case of chronic active hepatitis with primary hepatocellular carcinoma that lacked HBV DNA in the tumor, the nontumorous liver tissue, and serum. The individual lacked all serological markers for HBV infection. This report more fairly supports the association between hepatocellular carcinoma and chronic hepatitis not due to hepatitis B. Whether this is related specifically to a non-A, non-B hepatitis agent requires identification of the viral agents that cause non-A, non-B hepatitis.
非甲非乙型肝炎与肝细胞癌之间的关联是基于乙肝病毒(HBV)血清学标志物呈阴性得出的;然而,在缺乏HBV感染血清学标志物的个体中,已发现肝细胞癌含有乙肝病毒脱氧核糖核酸(HBV DNA)。因此,那些将肝细胞癌归因于非甲非乙型肝炎但未检测肿瘤中HBV DNA的报告值得怀疑。我们描述了一例患有原发性肝细胞癌的慢性活动性肝炎病例,该病例的肿瘤、非肿瘤性肝组织及血清中均缺乏HBV DNA。该个体缺乏所有HBV感染的血清学标志物。本报告更有力地支持了肝细胞癌与非乙型慢性肝炎之间的关联。这是否与非甲非乙型肝炎病原体有特定关系,需要鉴定导致非甲非乙型肝炎的病毒病原体。